Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105647226 | 10564722 | 6 | F | 20140923 | 20160708 | 20141105 | 20160713 | EXP | US-PFIZER INC-2014298448 | PFIZER | 71.00 | YR | M | Y | 91.00000 | KG | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105647226 | 10564722 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG, 3X/DAY | 1670400 | MG | Y | 18989 | 800 | MG | TABLET | TID | |||
| 105647226 | 10564722 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | 1670400 | MG | Y | 18989 | TABLET | ||||||||
| 105647226 | 10564722 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, 2X/DAY (BID) | Y | 0 | 1000 | MG | BID | ||||||
| 105647226 | 10564722 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 2.5 MG, 1X/DAY | Y | 0 | 2.5 | MG | QD | ||||||
| 105647226 | 10564722 | 5 | SS | ASA | ASPIRIN | 1 | Oral | 32.5 MG, 1X/DAY | Y | 0 | 32.5 | MG | QD | ||||||
| 105647226 | 10564722 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | MG, 1X/DAY | 0 | QD | |||||||||
| 105647226 | 10564722 | 7 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | QD | |||||||
| 105647226 | 10564722 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | QD | |||||||
| 105647226 | 10564722 | 9 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 2.5 MG, 1X/DAY | 0 | 2.5 | MG | QD | |||||||
| 105647226 | 10564722 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 1 DF (PUFF), AS NEEDED | 0 | 1 | DF | ||||||||
| 105647226 | 10564722 | 11 | C | LASIX | FUROSEMIDE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105647226 | 10564722 | 1 | Osteoarthritis |
| 105647226 | 10564722 | 2 | Rheumatoid arthritis |
| 105647226 | 10564722 | 3 | Diabetes mellitus |
| 105647226 | 10564722 | 4 | Hypertension |
| 105647226 | 10564722 | 5 | Cardiovascular event prophylaxis |
| 105647226 | 10564722 | 6 | Prophylaxis |
| 105647226 | 10564722 | 7 | Benign prostatic hyperplasia |
| 105647226 | 10564722 | 8 | Hypertension |
| 105647226 | 10564722 | 9 | Diabetes mellitus |
| 105647226 | 10564722 | 10 | Chronic obstructive pulmonary disease |
| 105647226 | 10564722 | 11 | Oedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105647226 | 10564722 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105647226 | 10564722 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105647226 | 10564722 | 1 | 20121028 | 20140930 | 0 | |
| 105647226 | 10564722 | 3 | 201008 | 201410 | 0 | |
| 105647226 | 10564722 | 4 | 201008 | 201410 | 0 | |
| 105647226 | 10564722 | 5 | 20100701 | 201410 | 0 | |
| 105647226 | 10564722 | 6 | 20121028 | 20140930 | 0 | |
| 105647226 | 10564722 | 7 | 199604 | 0 | ||
| 105647226 | 10564722 | 8 | 201008 | 0 | ||
| 105647226 | 10564722 | 9 | 201101 | 0 | ||
| 105647226 | 10564722 | 10 | 201009 | 0 | ||
| 105647226 | 10564722 | 11 | 201307 | 0 |